|
Market Closed -
Other stock markets
|
After hours 15:46:04 | |||
| 68.90 EUR | +0.58% |
|
68.80 | -0.15% |
| 03:06am | Orion's Investigational Drug Wins EU Orphan Drug Designation to Treat Malignant Mesothelioma | MT |
| 06-16 | Digia Unit to Provide Data Integration, AI Analytics for Finnish Health Sector Project | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORION OYJ | Other Pharmaceuticals | +0.58% | +2.53% | +8.25% | +7.82% | +89.03% | 11.04B |  |  |  |
- Stock Market
- Stocks
- ORNBV Stock
- Charts Orion Oyj
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
